Considering that the pro-fibrotic M2 phenotype was reprogrammed to the anti-fibrotic M1 phenotype upon CXCL11 treatment in vitro, it was reasonable to assume that CXCL11 could ameliorate BLM-induced PF in mice by modulating M2 macrophage polarization. Here, CXCL11 is linked to Bloom syndrome.